tag:blogger.com,1999:blog-4900303239154048192.post4597630269173020024..comments2024-03-06T06:34:42.881-05:00Comments on EconoSpeak: The 2017 Tax Cuts and Irish Jobs ActUnknownnoreply@blogger.comBlogger7125tag:blogger.com,1999:blog-4900303239154048192.post-83791765782808391532020-07-31T16:07:40.229-04:002020-07-31T16:07:40.229-04:00Great Article thank you!Great Article thank you!Austinhttps://appraisal.enrichedrealestate.comnoreply@blogger.comtag:blogger.com,1999:blog-4900303239154048192.post-22267084383951652782020-07-23T18:08:17.589-04:002020-07-23T18:08:17.589-04:00Thank you so much for sharing this awesome info! K...Thank you so much for sharing this awesome info! Keep posting,<br />Alexhttp://www.cutmytaxes.comnoreply@blogger.comtag:blogger.com,1999:blog-4900303239154048192.post-89564117226028749502020-07-21T15:23:23.646-04:002020-07-21T15:23:23.646-04:00PGL:
I was asked years ago to help Gilead Science...PGL:<br /><br />I was asked years ago to help Gilead Sciences come up with an honest analysis of what its Irish affiliate to pay the US parent for the phase II rights to its HIV treatments. Ireland took the risk of phase III trials which succeeded. My analysis suggested royalty rates near 20% of sales would be responsible for the phase II rights and it turns out that others in Big Pharma was making offers in the same ball park.<br /><br />Now some other transfer pricing practitioners would have written reports that put the royalty rates closer to 10% even if the U.S. did the phase III trials....<br /><br />[ Excellent and of immediate importance. ]Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-4900303239154048192.post-17332177682046178192020-07-21T15:21:04.135-04:002020-07-21T15:21:04.135-04:00Really helpful; these series of posts and this lat...Really helpful; these series of posts and this latest explanation are excellent.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-4900303239154048192.post-15038951046653054802020-07-21T15:16:13.668-04:002020-07-21T15:16:13.668-04:00My attempt to explain what Kaleberg suggested. I w...My attempt to explain what Kaleberg suggested. I was asked years ago to help Gilead Sciences come up with an honest analysis of what its Irish affiliate to pay the US parent for the phase II rights to its HIV treatments. Ireland took the risk of phase III trials which succeeded. My analysis suggested royalty rates near 20% of sales would be responsible for the phase II rights and it turns out that others in Big Pharma was making offers in the same ball park.<br /><br />Now some other transfer pricing practitioners would have written reports that put the royalty rates closer to 10% even if the U.S. did the phase III trials. After all - these clowns were both stupid and hacks. The folks at Gilead told them to go to hell. After all they wanted an honest analysis after all.<br /><br />It can be done if someone insists that the representatives of Big Pharma are forced to tell the truth. But who is going to do that if the IRS is hamstrunged? pglhttps://www.blogger.com/profile/05915702907755464623noreply@blogger.comtag:blogger.com,1999:blog-4900303239154048192.post-61223521487208204342020-07-21T14:53:18.614-04:002020-07-21T14:53:18.614-04:00Maybe we should focus on the under priced transfer...Maybe we should focus on the under priced transfer of IP? It should be easy enough to put together a loan and business plan to outbid the offshore holding company. A requirement for open bidding or requiring the sale of the IP if a better offer comes along might make sense.<br /><br />[ Please explain this further when possible. I do not quite understand. ]Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-4900303239154048192.post-55573953334640872662020-07-20T22:56:13.585-04:002020-07-20T22:56:13.585-04:00Maybe we should focus on the under priced transfer...Maybe we should focus on the under priced transfer of IP? It should be easy enough to put together a loan and business plan to outbid the offshore holding company. A requirement for open bidding or requiring the sale of the IP if a better offer comes along might make sense.Kaleberghttps://www.blogger.com/profile/05283840743310507878noreply@blogger.com